Researchers have uncovered key insights into how aging impairs the immune system, identifying the epigenetic networks that drive cellular senescence in CD8+ T cells, a

A groundbreaking study from the Tokyo University of Science is changing the way we understand the value of healthy living across the lifespan. Led by

Ultrahuman, a leader in digital health technology, and Click Therapeutics, a pioneer in software-based therapeutics, today announced a strategic partnership to launch the world’s first

Mitochondrial therapeutics company Vincere Biosciences has been awarded $5 million from The Michael J. Fox Foundation for Parkinson’s Research to advance its lead Parkinson’s program

A recent meta-analysis highlights that resistance exercise may offer significant cognitive benefits for older adults. Researchers systematically reviewed 17 randomized controlled trials involving 739 participants

A growing body of research indicates that variations in the APOE gene may be responsible for a far greater proportion of Alzheimer’s disease (AD) cases

For centuries, humans have dreamed of extending life, through Greek ambrosia, Taoist elixirs, or medieval “aqua vitae.” Until recently, meaningful progress was stalled, confined to

Aviceda Therapeutics, a clinical-stage biopharmaceutical company focused on novel therapies for retinal diseases, today announced topline results from its Phase 2b SIGLEC clinical trial evaluating

New research from Texas A&M University suggests that just 20 minutes of exercise, twice a week, may help slow cognitive decline in older adults at

Beacon Therapeutics today announced a key milestone in its mission to develop transformative treatments for inherited retinal disorders, having dosed the first patient in its